证券代码：002449 证券简称：国星光电 公告编号：2025-031 佛山市国星光电股份有限公司 关于受让基金认缴出资份额进展暨完成备案登记的公告 近日，公司收到基金管理人通知，该基金已完成上述份额转让事项的工商变 更登记手续，同时，在中国证券投资基金业协会完成备案手续，取得《私募投资 基金备案证明》，具体备案信息如下： 基金名称：广东广晟百千万高质量发展产业投资母基金合伙企业（有限合伙） 管理人名称：深圳市广晟私募基金管理有限公司 托管人名称：兴业银行股份有限公司 备案日期：2025 年 6 月 25 日 备案编码：SAZZ04 公司将持续关注基金的后续进展情况，按照有关法律法规的规定和要求，及 时履行信息披露义务。敬请广大投资者理性投资，注意投资风险。 特此公告。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、交易概述 为进一步优化资本结构、提升资金运作效率及效益，佛山市国星光电股份有 限公司（以下简称"公司"）以零对价受让广东省广晟资本投资有限公司持有的 广东广晟百千万高质量发展产业投资母基金合伙企业（有限合伙）1,120 万元基 金份额对应的 ...

佛山市国星光电股份有限公司 监事会 佛山市国星光电股份有限公司（以下简称"公司"）监事会于近日收到 公司职工代表监事曾默翔先生提交的辞职申请，曾默翔先生因个人原因申请 辞去公司第六届监事会职工代表监事职务，辞职后不再担任公司任何职务。 截至本公告日，曾默翔先生未持有公司股票。 根据《公司法》和《公司章程》等相关规定，公司于 2025 年 6 月 17 日召开了职工代表大会，选举梁丽芳女士（简历见附件）为公司职工代表监 事，任期与公司第六届监事会一致。 梁丽芳女士符合法律法规、规范性文件和《公司章程》等相关制度对职 工代表监事的任职资格要求，具备与其行使职权相适应的任职条件。不存在 《公司法》《公司章程》等法律法规、规范性文件规定的不得担任相关职务 的情形。 特此公告。 证券代码：002449 证券简称：国星光电 公告编号：2025-030 佛山市国星光电股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 附件：梁丽芳女士简历 梁丽芳女士：中国国籍，无境外永久居留权，1982 年 9 月出生，中共党 员，华南师范大学硕士研究生。历任国星光电研发中心专 ...

本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 佛山市国星光电股份有限公司（以下简称"公司"）监事会于近日收到 公司职工代表监事曾默翔先生提交的辞职申请，曾默翔先生因个人原因申请 辞去公司第六届监事会职工代表监事职务，辞职后不再担任公司任何职务。 截至本公告日，曾默翔先生未持有公司股票。 证券代码：002449 证券简称：国星光电 公告编号：2025-030 佛山市国星光电股份有限公司 关于变更职工代表监事的公告 根据《公司法》和《公司章程》等相关规定，公司于 2025 年 6 月 17 日召开了职工代表大会，选举梁丽芳女士（简历见附件）为公司职工代表监 事，任期与公司第六届监事会一致。 梁丽芳女士符合法律法规、规范性文件和《公司章程》等相关制度对职 工代表监事的任职资格要求，具备与其行使职权相适应的任职条件。不存在 《公司法》《公司章程》等法律法规、规范性文件规定的不得担任相关职务 的情形。 附件：梁丽芳女士简历 梁丽芳女士：中国国籍，无境外永久居留权，1982 年 9 月出生，中共党 员，华南师范大学硕士研究生。历任国星光电研发中心专利工程师、副主任 工 ...

Group 1 - The core viewpoint is that the aging lighting market is an emerging opportunity for LED lighting companies, but the penetration rate of specialized aging lighting modifications is currently below 5% in China, facing challenges such as a lack of standards [3][6][7] - The "silver economy" market, which is valued in trillions, is increasingly recognized, with the elderly population in China projected to exceed 300 million by 2024, accounting for 22% of the total population [4][6][7] - Companies are shifting from price competition to developing high-value-added products, with smart lighting, human-centric lighting, and health lighting being key development directions [3][4] Group 2 - Major LED companies, including Mulinson and Foshan Lighting, are experiencing varying degrees of performance decline due to external trade environment changes and industry price drops [4][5] - The integration of AI technology into aging lighting solutions is seen as a new opportunity, with companies like Signify launching products that monitor elderly individuals' safety [4][5] - The current lack of standards for aging lighting leads to the prevalence of "pseudo-aging lighting products," highlighting the need for research and development of appropriate lighting formulas based on the physiological needs of the elderly [6][7][8] Group 3 - The aging population presents unique physiological challenges, such as reduced light transmission in the eyes, necessitating tailored lighting solutions to enhance safety and well-being [7][8] - The market for home modifications for the elderly is estimated to be worth 3 trillion yuan, yet the penetration of specialized lighting modifications remains low [7][8] - A proposed solution involves creating a "medical-industry-policy" triangle to establish clinical databases and develop dynamic lighting formulas that cater to various health conditions [8]

沪指6月12日上涨0.01%，申万所属行业中，今日上涨的有15个，涨幅居前的行业为有色金属、传媒， 涨幅分别为1.40%、1.33%。跌幅居前的行业为家用电器、煤炭，跌幅分别为1.77%、1.14%。电子行业 今日下跌0.27%。 资金面上看，两市主力资金全天净流出105.88亿元，今日有9个行业主力资金净流入，医药生物行业主 力资金净流入规模居首，该行业今日上涨1.27%，全天净流入资金11.01亿元，其次是银行行业，日涨幅 为0.30%，净流入资金为9.88亿元。 主力资金净流出的行业有22个，电子行业主力资金净流出规模居首，全天净流出资金22.25亿元，其次 是汽车行业，净流出资金为16.25亿元，净流出资金较多的还有国防军工、基础化工、计算机等行业。 电子行业今日下跌0.27%，全天主力资金净流出22.25亿元，该行业所属的个股共462只，今日上涨的有 179只，涨停的有4只；下跌的有271只。以资金流向数据进行统计，该行业资金净流入的个股有162只， 其中，净流入资金超亿元的有10只，净流入资金居首的是沃尔核材，今日净流入资金5.31亿元，紧随其 后的是沪电股份、国星光电，净流入资金分别为2.33亿 ...

Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

佛山市国星光电股份有限公司(以下简称"公司")2024 年年度权益分派方 案已获 2025 年 5 月 16 日召开的 2024 年度股东会审议通过，现将权益分派事宜 公告如下： 一、股东会审议通过利润分配方案情况 证券代码：002449 证券简称：国星光电 公告编号：2025-029 佛山市国星光电股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 以 2024 年年末总股本 618,477,169 股为基数，向全体股东每 10 股派现金股 利 0.5 元（含税），总计分配 3,092.39 万元，剩余累计未分配利润结转下年度。 除上述现金分红外，本次分配公司不送红股，不实施资本公积金转增股本。 实施前公司总股本发生变动的，公司将按照"分配总额不变"的原则对分配比例 进行调整。 二、权益分派方案 度利润分配预案》，公司 2024 年度利润分配方案为： 本公司 2024 年年度权益分派方案为：以公司现有总股本 618,477,169 股为 基数，向全体股东每 10 股派 0.500000 元人民币现金（含税；扣税后，通过深 股通持有股份的香港市场投 ...

证券代码：002449 证券简称：国星光电 公告编号：2025-029 佛山市国星光电股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 佛山市国星光电股份有限公司(以下简称"公司")2024 年年度权益分派方 案已获 2025 年 5 月 16 日召开的 2024 年度股东会审议通过，现将权益分派事宜 公告如下： 一、股东会审议通过利润分配方案情况 1、公司于 2025 年 5 月 16 日召开的 2024 年度股东会审议通过了《2024 年 度利润分配预案》，公司 2024 年度利润分配方案为： 以 2024 年年末总股本 618,477,169 股为基数，向全体股东每 10 股派现金股 利 0.5 元（含税），总计分配 3,092.39 万元，剩余累计未分配利润结转下年度。 除上述现金分红外，本次分配公司不送红股，不实施资本公积金转增股本。 2、本次实施的分配方案与股东会审议通过的分配方案一致。 3、自分配方案披露日至实施期间公司股本总额未发生变化。若在分配方案 实施前公司总股本发生变动的，公司将按照"分配总 ...

Group 1 - The core viewpoint of the articles highlights the positive operational developments of listed companies in the second quarter of 2025, showcasing advancements in various sectors such as semiconductors, robotics, new energy, and new materials [2][3] - Companies are actively sharing updates on project progress, new technologies, and orders, indicating a trend of industrial upgrades and strategic transformations [2][3] - High-growth sectors continue to exhibit strong growth momentum, while cyclical industries are seeking balance amid supply-demand adjustments [3] Group 2 - Chip companies are benefiting from the AI industry, with interconnect chip orders exceeding RMB 12.9 billion as of April 22, 2025, and expectations for significant growth in DDR5 memory interface chip demand [4] - Traditional cyclical industries like coal and chemicals are showing resilience through cost control and structural optimization, with companies like Guanghui Energy anticipating stabilization in coal prices due to various market factors [4][5] - Manufacturing companies are focusing on improving production efficiency and meeting customer demands, with firms like Xinqianglian and Guangxin Materials reporting strong order backlogs and plans for product launches [5] Group 3 - Many listed companies are already building momentum for annual revenue growth, particularly in emerging sectors like new energy and robotics, with plans for market expansion and quality enhancement through mergers and acquisitions [6] - Companies like Longmag Technology are localizing raw material supply to reduce production costs and enhance supply chain stability [6] - Hechuan Technology is actively developing humanoid robots and plans to launch new products in the second half of 2025 [6] Group 4 - The new merger regulations have made acquisitions a key strategy for A-share companies to optimize resource allocation, with firms like Chenhua Co. targeting investments in new materials and fine chemical agents [7] - Guoxing Optoelectronics is focusing on upstream and downstream opportunities in the LED and optical sensing sectors, while Zhenbaodao is exploring new industries through asset acquisitions [7] - Huichuan Technology is looking for overseas acquisition opportunities, concentrating on automation, digitalization, and intelligent sectors that align with its core business [7]

Group 1: Business Strategy and Future Directions - The company plans to optimize its layout and actively engage in investment and mergers, focusing on expanding into emerging industries such as LED applications, optical sensing, and intelligent systems [1] - Future capital investments will target new fields including third-generation semiconductors and advanced semiconductor packaging [1] - The company aims to enhance its product offerings in the automotive sector, particularly in LED products used by major manufacturers like Changan and BYD [2] Group 2: Product Development and Competitive Advantages - The company has a strong competitive edge due to its technological innovation, with over 1,200 patents filed and more than 840 granted, establishing a solid technical barrier [2] - The new AS series panel utilizes a "MIP + module + GOB" technology integration, enhancing display quality and reliability while reducing costs [3] - The company is developing optical sensing products for automotive applications, specifically for AEBS systems [1] Group 3: Market Outlook and Industry Trends - The domestic LED industry is expected to benefit from the ongoing push for localization and technological advancements, particularly in high-value sectors [3] - Emerging markets, such as those related to the Belt and Road Initiative, are anticipated to provide new growth opportunities for the industry [4] - The company is optimistic about the future of the LED market, driven by technological maturity and cost optimization [3] Group 4: Financial Performance and Growth Opportunities - The company has seen growth in its automotive LED and optical sensing sectors, with plans to continue developing new products and exploring acquisition opportunities [5] - Despite recent declines in overall business performance, the company is committed to diversifying its product range and enhancing its market presence [6] - The company is focused on maintaining a stable cash dividend policy to support investor interests amid fluctuating stock prices [7] Group 5: Strategic Adjustments and Future Plans - The company is restructuring its strategy around three pillars: core industries, foundational industries, and emerging industries, to enhance business synergy [6] - Plans include deepening cooperation with key customers and improving product value attributes in foundational industries [6] - The company is actively seeking quality acquisition targets in the LED and optical sensing sectors to strengthen its market position [6]